The US Food and Drug Administration (FDA) has approved Wright Medical Group’s hip resurfacing system to give surgeons an alternative to hip replacement therapy.

The Conserve Plus Total Hip Resurfacing System, available in the US, provides surgeons and patients with a bone-conserving alternative to traditional total hip replacement, the company said.

Wright will be able to initiate efforts to introduce additional enhancements to the system, which at the moment are available only outside the US.

Hip resurfacing could be used for young active patients in need of surgical treatment for chronic pain, the company said.

The system is designed to offer pain relief and restoration of function, simultaneously retaining as much healthy bone as possible and preserving future surgery options, Wright said.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData